A brief introduction to Central Serous Chorioretinopathy (CSCR)
Central Serous Chorioretinopaty (CSCR) is an idiopathic condition which affects the central area of vision. Those affected are mainly young people between the ages of 20-55 and to a great degree is self-limiting (subsides by itself). The cause of CSCR remains unknown. It usually appears as a blurring or even deformation of the central vision such as when driving or reading, in one eye. Its appearance often is due to long periods of anxiety, a regular or a local use of cortisone or during the period of pregnancy.
Its manifestation is of high scientific interest as in people with a personality of type A (ambitious and active people, meticulous with heavy workload), in patients with Cushing Syndrome and in those with Central Sleep Apnea Syndrome. This pathologic condition is developed when fluid collection appears between the layers of the retina coming from the choroid coat.
Even if it is characterized as a benign condition, it causes severe impairment of vision in its repetitive and chronic forms. The fluid collection can be expressed in two forms, the acute and the chronic one.
The chronic form can be expressed with multiple recurring symptoms with only one episode that insists for more than four to six months without fluid absorption.
The prognosis of the condition is good, as in a two months period the fluid is absorbed without treatment and the symptoms subside.
In about 50% of patients relapses of the condition are being observed, while 10% of the patients, especially the elderly, the condition becomes chronic and may lead to atrophy of the retinal pigment epithelium and permanent vision loss.
The Diagnostic Process
The following tests are performed for the diagnosis of the condition:
- Measurement of Vision Acuity
- Amsler Grid Test
- Retinoscopy using Mydriasis
- Optical Coherence Tomography (OCT) of the contralateral hemisphere
- Fluorescent Angiography
In more details:
Optical Coherence Tomography (OCT) is a crucial examination for the diagnosis of the condition illustrating the fluid accumulation under the Macula. One equally important examination for the Central Serous Chorioretinopathy is that of fluorescent angiography illustrating with high clarity the fluid leak points, which guides the doctor for the medical intervention.
Due to the high possibility that the condition may subside automatically, the Central Serous Chorioretinopathy(CSCR) is first treated without any serious intervention.
In about 90% of the cases, the condition can be self-limiting, as it regresses without any treatments. The Central Serous Chorioretinopathy, has to be suppressed in the first three months of its onset or if its clinical picture resembles that of a permanent damage in the central vision, a therapeutic intervention is advised.
Patients with Central Serous Chorioretinopathy, which is clinically diagnosed and illustratively confirmed with Optical Coherence Tomography of the contralateral hemisphere are asked to follow:
- Re-examination every 4 months
- Stopage of any use of cortisone on a regular basis or locally, if this is possible
- Lifestyle change and stress reduction
How Central Serous Chorioretinopathy is treated?
An innovative medical approach, except for the invasive treatment with laser, is by Medical Acupuncture, which is performed by the experienced and specialized medical team of Orasis Acupunture Institute. The placement of needles takes place on specific body points as our doctors-acupuncturists implement personalized protocols, on a frequent basis. The improvement as well as the results will be visible to the patient.
Our medical team relies on the patient’s specific pathology and takes into consideration his clinical status and his medical examination results, as well.
At our Institute, in the period of Covid-19, we care about your safety and we implement all the prescribed health protocols of the Greek Ministry of Health and the Infectious Diseases Commission of EODY.